$0 Profit
KYTXLong Stock
Zachary_Brammer

News: "Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome" A 9% maximum profit potential with my risk parameters. My profit: 2.08%. I bought at 09:43:04 and sold at 09:43:17.

000

DatePrice
Entry12/15/202512.50
Exit12/15/202512.76
  • Total Views7
  • Position Size1
  • Percentage2.08%
Proof
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
Join now or log in to leave a comment